{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The long-running criminal investigation of possible fraud at HCA Inc. reached a turning point yesterday, with the government disclosing that federal prosecutors in Florida had closed their inquiry into possible wrongdoing by people associated with HCA, the giant hospital chain. The decision by Florida prosecutors, disclosed by the Justice Department in a filing with the Federal District Court in Washington, clears the way for HCA executives to begin giving sworn depositions in a large civil action by the government accusing the company of defrauding health programs like Medicare.", "headline": {"main": "Staff Is Cleared, But HCA Suit Will Proceed"}, "abstract": "Long-running criminal investigation of possible fraud at HCA Inc reaches turning point, with government disclosing that federal prosecutors in Florida closed inquiry into possible wrongdoing by people associated with HCA; decision clears way for HCA executives to begin giving sworn depositions in large civil action by government accusing company of defrauding health programs like Medicare; possibility of indictments against individuals has been logjam in civil case for months; HCA pleaded guilty in December 2000 to 14 criminal counts and paid government $840 million to end most of fraud case; government has contended there was $650 million more in fraud related to improper Medicare reimbursement claims and kickbacks to doctors (M)", "print_page": "5", "word_count": 437, "_id": "4fd21cfd8eb7c8105d79d91e", "snippet": "The long-running criminal investigation of possible fraud at HCA Inc. reached a turning point yesterday, with the government disclosing that federal prosecutors in Florida had closed their inquiry into possible wrongdoing by people associated with...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/17/business/staff-is-cleared-but-hca-suit-will-proceed.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "JUSTICE DEPARTMENT"}, {"name": "organizations", "value": "HCA-THE HEALTHCARE CO"}, {"name": "subject", "value": "FRAUDS AND SWINDLING"}, {"name": "subject", "value": "FINES (PENALTIES)"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "MALPRACTICE"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "BRIBERY"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "HOSPITALS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Kurt", "lastname": "EICHENWALD"}], "original": "By KURT EICHENWALD"}, "document_type": "article", "pub_date": "2002-07-17T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Democrats and Republicans wrangled today over proposals to lower the cost of prescription drugs and to provide drug benefits to the elderly, as the Senate lurched into an open-ended debate whose outcome was uncertain. Partisan tensions flared immediately. Democrats said Republicans were stalling the legislation, at the behest of the drug industry.", "headline": {"main": "Charges of Politics Fire Senate's Drug Debate"}, "abstract": "Senate Democrats and Republicans wrangle over proposals to lower cost of prescription drugs and to provide Medicare drug benefits to elderly, as charges of partisanship and trying to derail legislation are traded; Senate committee last week approved bill to expand access to low-cost generic drugs but rather than taking up bill itself, Senate remains mired in debate over motion to proceed to its consideration; photo (M)", "print_page": "17", "word_count": 833, "_id": "4fd232a78eb7c8105d7c2a3c", "snippet": "Democrats and Republicans wrangled today over proposals to lower the cost of prescription drugs and to provide drug benefits to the elderly, as the Senate lurched into an open-ended debate whose outcome was uncertain.    Partisan tensions flared...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/17/us/charges-of-politics-fire-senate-s-drug-debate.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-07-17T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Senate began a boisterous election-year debate on prescription drugs today as Democrats and Republicans unveiled competing proposals to add drug benefits to Medicare and to rein in pharmaceutical costs. Senator Judd Gregg, Republican of New Hampshire, objected tonight when Democrats asked for unanimous consent to take up a bill expanding access to low-cost generic versions of brand-name drugs. The objection forced Democrats to make a formal motion to proceed, ensuring that no swift action would occur.", "headline": {"main": "Senate Begins Debate on Rival Medicare Prescription Plans"}, "abstract": "Senate begins debate on prescription drugs as Democrats and Republicans unveil competing proposals to add drug benefits to Medicare and to rein in pharmaceutical costs; Democrats fail to get unanimous consent to take up bill expanding access to low-cost generic versions of brand-name drugs, thus ensuring that no swift action will occur on legislation approved in committee last week; photo (M)", "print_page": "12", "word_count": 882, "_id": "4fd27f578eb7c8105d849286", "snippet": "The Senate began a boisterous election-year debate on prescription drugs today as Democrats and Republicans unveiled competing proposals to add drug benefits to Medicare and to rein in pharmaceutical costs.    Senator Judd Gregg, Republican of New...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/16/us/senate-begins-debate-on-rival-medicare-prescription-plans.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-07-16T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "A proposed deal that would have ended a monthlong strike by workers for three private bus companies in Queens fell apart yesterday evening amid what appeared to be a rift within the workers' union. Under the proposal, put forth last week by the Queens borough president, 1,500 striking drivers, mechanics and cleaners would have returned to work this morning, ending a strike that has inconvenienced more than 115,000 people who ride those buses daily. The workers would have received increases in health benefits with the help of a $2 million city loan.", "headline": {"main": "A Deal Falters, And Buses Stay Parked In Queens"}, "abstract": "Proposal that would have ended monthlong strike by workers for three private bus companies in Queens falls apart; rift within workers' union is blamed, and tension is high as fistfight breaks out between members of disagreeing factions; workers complain that health benefits are not only issue and deal arrived at by Borough Pres Helen Marshall and others does not address concerns about job security; Mayor Michael Bloomberg says he wants to see routes taken over by Metropolitan Transportation Authority, whose workers are barred from striking (M)", "print_page": "1", "word_count": 707, "_id": "4fd237d08eb7c8105d7ca929", "snippet": "A proposed deal that would have ended a monthlong strike by workers for three private bus companies in Queens fell apart yesterday evening amid what appeared to be a rift within the workers' union.    Under the proposal, put forth last week by the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/15/nyregion/a-deal-falters-and-buses-stay-parked-in-queens.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "MARSHALL, HELEN"}, {"name": "persons", "value": "BLOOMBERG, MICHAEL R"}, {"name": "glocations", "value": "QUEENS (NYC)"}, {"name": "organizations", "value": "METROPOLITAN TRANSPORTATION AUTHORITY"}, {"name": "organizations", "value": "TRIBORO COACH CORP"}, {"name": "organizations", "value": "JAMAICA BUSES"}, {"name": "organizations", "value": "QUEENS SURFACE CORP"}, {"name": "subject", "value": "BUSES"}, {"name": "subject", "value": "LABOR"}, {"name": "subject", "value": "FRINGE BENEFITS"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "TRANSIT SYSTEMS"}, {"name": "subject", "value": "STRIKES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Elissa", "lastname": "GOOTMAN"}], "original": "By ELISSA GOOTMAN"}, "document_type": "article", "pub_date": "2002-07-15T00:00:00Z", "section_name": "Health; New York and Region"}, {"type_of_material": "An Analysis; News Analysis", "blog": [], "news_desk": "National Desk", "lead_paragraph": "It is discover or die for pharmaceutical companies, and most of them have been having a hard time finding breakthrough prescription drugs that would assure the robust future growth in annual earnings that investors demand. Pharmacia, a medium-size international drug maker formerly known as Pharmacia & Upjohn, has decided that the safest course is to bury its identity. In a deal expected to be announced today, Pfizer would pay $60 billion in stock to buy Pharmacia. As a minority owner, Pharmacia would hold 23 percent of Pfizer, the current king of the splintered pharmaceutical industry.", "headline": {"main": "Burying Its Identity"}, "abstract": "News analysis of planned acquisition of Pharmacia by Pfizer; Pharmacia, amalgam of half-dozen American and European drug companies, has decided on safest course in market that loves robust growth but in which manufacturers are facing challenges on several fronts; aging Americans are calling for Medicaid-financed drug benefit that would pose threat of government pressure on industry to keep prices down; Congress is considering fistful of bills that would make it harder for drug companies to extend life of patent monopolies that protect their products from lower-cost generics (M)", "print_page": "13", "word_count": 583, "_id": "4fd280d68eb7c8105d84c7b6", "snippet": "It is discover or die for pharmaceutical companies, and most of them have been having a hard time finding breakthrough prescription drugs that would assure the robust future growth in annual earnings that investors demand.    Pharmacia, a medium-size...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/15/us/burying-its-identity.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "PHARMACIA CORP"}, {"name": "organizations", "value": "PFIZER INC"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "INVENTIONS AND PATENTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2002-07-15T00:00:00Z", "section_name": "Technology; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "When the Senate begins a two-week debate on prescription drugs on Monday, Senator Debbie Stabenow will be at the center of the action, leading Democratic efforts to provide Medicare drug benefits and rein in pharmaceutical costs. Ms. Stabenow, a lifelong resident of Michigan, personifies the political power of the issue. She rode it to victory in 2000, and many other Democrats hope to do so this fall.", "headline": {"main": "Michigan Senator Who Ran on Drug Issue Will Lead Democrats in Debate"}, "abstract": "Article profiles Michigan Democratic Sen Debbie Stabenow, who will lead Senate Democrats in two-week debate on prescription drugs aimed at providing Medicare drug benefits and reigning in pharmaceutical costs; lifelong resident of Michigan personifies political power of issue, which she rode to victory in 2000; photo (M)", "print_page": "12", "word_count": 854, "_id": "4fd232a38eb7c8105d7c26ad", "snippet": "When the Senate begins a two-week debate on prescription drugs on Monday, Senator Debbie Stabenow will be at the center of the action, leading Democratic efforts to provide Medicare drug benefits and rein in pharmaceutical costs.    Ms. Stabenow, a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/15/us/michigan-senator-who-ran-on-drug-issue-will-lead-democrats-in-debate.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "STABENOW, DEBBIE"}, {"name": "glocations", "value": "MICHIGAN"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "ELECTIONS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-07-15T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 16, "offset": 10, "time": 254}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}